Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bassam R Ali

Showing results (21-30 of 173) with videos related to

Pageof 18
Sort By:
Acta Pharmaceutica (Zagreb, Croatia)|January 19, 2023
Computer-aided approaches reveal trihydroxychroman and pyrazolone derivatives as potential inhibitors of SARS-CoV-2 virus main proteaseNoor Atatreh, Shaima Hasan, Bassam R Ali, et al.
Expert Opinion on Drug Metabolism & Toxicology|June 15, 2021
Current opinion on the pharmacogenomics of paclitaxel-induced toxicityZeina N Al-Mahayri, Mohammad M AlAhmad, Bassam R Ali
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 16, 2022
Mendelian randomization in pharmacogenomics: The unforeseen potentialsLubna Q Khasawneh, Zeina N Al-Mahayri, Bassam R Ali
Frontiers in Pharmacology|December 18, 2023
Antihypertensives associated adverse events: a review of mechanisms and pharmacogenomic biomarkers available evidence in multi-ethnic populationsSahar M Altoum, Zeina N Al-Mahayri, Bassam R Ali
Frontiers in Pharmacology|May 1, 2020
Toxicity and Pharmacogenomic Biomarkers in Breast Cancer ChemotherapyZeina N Al-Mahayri, George P Patrinos, Bassam R Ali
Lipids in Health and Disease|May 29, 2023
GRP78/BiP alleviates oxLDL-induced hepatotoxicity in familial hypercholesterolemia caused by missense variants of LDLR in a HepG2 cellular modelDivya Saro Varghese, Deepu Oommen, Anne John, et al.
Gene|February 18, 2015
Defective cellular trafficking of the bone morphogenetic protein receptor type II by mutations underlying familial pulmonary arterial hypertensionAnne John, Praseetha Kizhakkedath, Lihadh Al-Gazali, et al.
Frontiers in Oncology|November 1, 2021
Long-Term Effects of Pediatric Acute Lymphoblastic Leukemia Chemotherapy: Can Recent Findings Inform Old Strategies?Zeina N Al-Mahayri, Mohammad M AlAhmad, Bassam R Ali
Scientific Reports|January 27, 2018
Degradation routes of trafficking-defective VLDLR mutants associated with Dysequilibrium syndromePraseetha Kizhakkedath, Anne John, Lihadh Al-Gazali, et al.
Frontiers in Molecular Biosciences|March 14, 2022
Endoglin Wild Type and Variants Associated With Hereditary Hemorrhagic Telangiectasia Type 1 Undergo Distinct Cellular Degradation PathwaysNesrin Gariballa, Praseetha Kizhakkedath, Nadia Akawi, et al.
Pageof 18

Showing results (21-30 of 173) with videos related to

Sort By:
Pageof 18
Acta Pharmaceutica (Zagreb, Croatia)|January 19, 2023
Computer-aided approaches reveal trihydroxychroman and pyrazolone derivatives as potential inhibitors of SARS-CoV-2 virus main proteaseNoor Atatreh, Shaima Hasan, Bassam R Ali, et al.
Expert Opinion on Drug Metabolism & Toxicology|June 15, 2021
Current opinion on the pharmacogenomics of paclitaxel-induced toxicityZeina N Al-Mahayri, Mohammad M AlAhmad, Bassam R Ali
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 16, 2022
Mendelian randomization in pharmacogenomics: The unforeseen potentialsLubna Q Khasawneh, Zeina N Al-Mahayri, Bassam R Ali
Frontiers in Pharmacology|December 18, 2023
Antihypertensives associated adverse events: a review of mechanisms and pharmacogenomic biomarkers available evidence in multi-ethnic populationsSahar M Altoum, Zeina N Al-Mahayri, Bassam R Ali
Frontiers in Pharmacology|May 1, 2020
Toxicity and Pharmacogenomic Biomarkers in Breast Cancer ChemotherapyZeina N Al-Mahayri, George P Patrinos, Bassam R Ali
Lipids in Health and Disease|May 29, 2023
GRP78/BiP alleviates oxLDL-induced hepatotoxicity in familial hypercholesterolemia caused by missense variants of LDLR in a HepG2 cellular modelDivya Saro Varghese, Deepu Oommen, Anne John, et al.
Gene|February 18, 2015
Defective cellular trafficking of the bone morphogenetic protein receptor type II by mutations underlying familial pulmonary arterial hypertensionAnne John, Praseetha Kizhakkedath, Lihadh Al-Gazali, et al.
Frontiers in Oncology|November 1, 2021
Long-Term Effects of Pediatric Acute Lymphoblastic Leukemia Chemotherapy: Can Recent Findings Inform Old Strategies?Zeina N Al-Mahayri, Mohammad M AlAhmad, Bassam R Ali
Scientific Reports|January 27, 2018
Degradation routes of trafficking-defective VLDLR mutants associated with Dysequilibrium syndromePraseetha Kizhakkedath, Anne John, Lihadh Al-Gazali, et al.
Frontiers in Molecular Biosciences|March 14, 2022
Endoglin Wild Type and Variants Associated With Hereditary Hemorrhagic Telangiectasia Type 1 Undergo Distinct Cellular Degradation PathwaysNesrin Gariballa, Praseetha Kizhakkedath, Nadia Akawi, et al.
Pageof 18